Business Description
Azitra Inc
NAICS : 541714
SIC : 2834
ISIN : US05479L3024
Total Employee Number:
13Description
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 29.22 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 76.6 | |||||
3-Year EPS without NRI Growth Rate | 78.2 | |||||
3-Year FCF Growth Rate | 74.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 62.11 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 29.86 | |||||
9-Day RSI | 33.3 | |||||
14-Day RSI | 35.9 | |||||
3-1 Month Momentum % | -1.36 | |||||
6-1 Month Momentum % | -26.57 | |||||
12-1 Month Momentum % | -86.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.94 | |||||
Quick Ratio | 6.94 | |||||
Cash Ratio | 6.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -463.6 | |||||
Shareholder Yield % | -863.14 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -254.67 | |||||
ROA % | -188.64 | |||||
ROIC % | -495.47 | |||||
3-Year ROIIC % | 152.52 | |||||
ROC (Joel Greenblatt) % | -1141.57 | |||||
ROCE % | -244.14 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.2 | |||||
Price-to-Tangible-Book | 0.2 | |||||
EV-to-EBIT | 0.65 | |||||
EV-to-EBITDA | 0.67 | |||||
EV-to-Forward-Revenue | 1.21 | |||||
EV-to-FCF | 0.71 | |||||
| Price-to-Net-Current-Asset-Value | 0.23 | |||||
| Price-to-Net-Cash | 0.24 | |||||
Earnings Yield (Greenblatt) % | 153.85 | |||||
FCF Yield % | -525.63 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:AZTR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Azitra Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.327 | ||
| Beta | -1.1584 | ||
| 3-Year Sharpe Ratio | -2.21 | ||
| 3-Year Sortino Ratio | -2.02 | ||
| Volatility % | 69.37 | ||
| 14-Day RSI | 35.9 | ||
| 14-Day ATR ($) | 0.016981 | ||
| 20-Day SMA ($) | 0.14705 | ||
| 12-1 Month Momentum % | -86.71 | ||
| 52-Week Range ($) | 0.1 - 1.571759 | ||
| Shares Outstanding (Mil) | 16.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Azitra Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Azitra Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-12 | In 111 days | ||
| Second quarter earnings results for 2026 | 2026-08-11 | In 18 days | ||
| General meeting for 2026 | 2026-06-15 11:00 | 0.21 (-1.81%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 0.22 (-4.97%) | ||
| Annual report for 2025 | 2026-02-27 | 0.18 (-1.67%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-27 | 0.18 (-1.67%) | ||
| Third quarter earnings results for 2025 | 2025-11-12 | 0.40 (+3.39%) | ||
| 0.15015:1 Stock Split | 2025-08-21 | 0.90 (-2.24%) | ||
| Second quarter earnings results for 2025 | 2025-08-11 | 1.09 (-3.13%) | ||
| General meeting for 2025 | 2025-06-23 11:00 | 1.64 (-1.75%) |
Show
Entries
Azitra Inc Frequently Asked Questions
What is Azitra Inc(AZTR)'s stock price today?
The current price of AZTR is $0.13. The 52 week high of AZTR is $1.57 and 52 week low is $0.10.
When is next earnings date of Azitra Inc(AZTR)?
The next earnings date of Azitra Inc(AZTR) is 2026-08-11 Est..
Does Azitra Inc(AZTR) pay dividends? If so, how much?
Azitra Inc(AZTR) does not pay dividend.
Guru Commentaries on AMEX:AZTR
No articles.
Press Release
Articles on Azitra Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers